Clinical Trial Update: Counseling Among Gender Diverse Adolescents Who Use Depot Medroxyprogesterone [Phase 4]

View source ↗

Summary

This Phase 4 clinical trial update reports completion and posted results of a study examining counseling for gender-diverse adolescents who use depot medroxypro…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gender Dysphoria in Adolescence

Drugs mentioned

• Depo-Provera (medroxyprogesterone acetate)

Snippet

Sponsor: University of Colorado, Denver | Conditions: Gender Dysphoria, Adolescent | Phase 4 | Status: COMPLETED | Results posted: 2026-02-12